tirzepatide side effects vs semaglutide side effects Weighing up the Risks: GI of Semaglutide vs. Tirzepatide for Weight

Warning signs include sudden leg swelling with pain and warmth, sudden shortness of breath or chest pain, coughing up blood, or stroke symptoms like facial drooping and speech difficulty

The dual incretin agonists segment held a 23% share of the market in 2025 and is expected to grow at a CAGR of 18.5% during the projection period

Retatrutide (LY-3437943) is a next-generation triple incretin receptor agonist that simultaneously activates the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)

For weight loss, these drugs work by making you feel less hungry

For perspective, fatigue affects 3-7% of users and is more commonly reported than anxiety